Ongoing Remission Nineteen Years after High-dose Chemotherapy for Oligometastatic Breast Cancer; What Can We Learn from this Patient?

Por Steenbruggen, Tessa G, Linn, Sabine C, Rodenhuis, Sjoerd, Sonke, Gabe S
Publicado no Cureus (2015)

Identifying subgroup markers in heterogeneous populations

Por de Ronde, Jorma J., Rigaill, Guillem, Rottenberg, Sven, Rodenhuis, Sjoerd, Wessels, Lodewyk F. A.
Publicado em 2013

Population pharmacokinetics of orally administered paclitaxel formulated in Cremophor EL

Por de Jonge, Milly E, Huitema, Alwin DR, Schellens, Jan HM, Rodenhuis, Sjoerd, Beijnen, Jos H
Publicado em 2005

Breast Cancer Subtype Specific Classifiers of Response to Neoadjuvant Chemotherapy Do Not Outperform Classifiers Trained on All Subtypes

Por de Ronde, Jorma J., Bonder, Marc Jan, Lips, Esther H., Rodenhuis, Sjoerd, Wessels, Lodewyk F. A.
Publicado em 2014

Polymorphisms of drug-metabolizing enzymes (GST, CYP2B6 and CYP3A) affect the pharmacokinetics of thiotepa and tepa

Por Ekhart, Corine, Doodeman, Valerie D, Rodenhuis, Sjoerd, Smits, Paul H M, Beijnen, Jos H, Huitema, Alwin D R
Publicado em 2009

Population pharmacokinetics of thioTEPA and its active metabolite TEPA in patients undergoing high-dose chemotherapy

Por Huitema, Alwin D R, Mathôt, Ron A A, Tibben, Matthijs M, Schellens, Jan H M, Rodenhuis, Sjoerd, Beijnen, Jos H
Publicado em 2001

Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancer

Por Loo, Claudette E., Rigter, Lisanne S., Pengel, Kenneth E., Wesseling, Jelle, Rodenhuis, Sjoerd, Peeters, Marie-Jeanne T. F. D. Vrancken, Sikorska, Karolina, Gilhuijs, Kenneth G. A.
Publicado no Breast Cancer Res (2016)

Quantitative copy number analysis by Multiplex Ligation-dependent Probe Amplification (MLPA) of BRCA1-associated breast cancer regions identifies BRCAness

Por Lips, Esther H, Laddach, Nadja, Savola, Suvi P, Vollebergh, Marieke A, Oonk, Anne MM, Imholz, Alex LT, Wessels, Lodewyk FA, Wesseling, Jelle, Nederlof, Petra M, Rodenhuis, Sjoerd
Publicado em 2011

Next generation sequencing of triple negative breast cancer to find predictors for chemotherapy response

Por Lips, Esther H., Michaut, Magali, Hoogstraat, Marlous, Mulder, Lennart, Besselink, Nicolle JM, Koudijs, Marco J., Cuppen, Edwin, Voest, Emile E., Bernards, Rene, Nederlof, Petra M., Wesseling, Jelle, Rodenhuis, Sjoerd, Wessels, Lodewyk FA
Publicado no Breast Cancer Res (2015)

Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy

Por Vollebergh, Marieke A, Lips, Esther H, Nederlof, Petra M, Wessels, Lodewyk FA, Wesseling, Jelle, vd Vijver, Marc J, de Vries, Elisabeth GE, van Tinteren, Harm, Jonkers, Jos, Hauptmann, Michael, Rodenhuis, Sjoerd, Linn, Sabine C
Publicado em 2014

Haptoglobin phenotype is not a predictor of recurrence free survival in high-risk primary breast cancer patients

Por Harris Nathan, de Vries Elisabeth GE, Tjan-Heijnen Vivianne CG, Span Paul N, Rodenhuis Sjoerd, Nooij Marianne A, van Hoesel René QGCM, Bontenbal Marijke, van Tinteren Harm, Gast Marie-Christine W, Twisk Jos WR, Schellens Jan HM, Beijnen Jos H
Publicado em 2008-12-01

Haptoglobin phenotype is not a predictor of recurrence free survival in high-risk primary breast cancer patients

Por Gast, Marie-Christine W, van Tinteren, Harm, Bontenbal, Marijke, van Hoesel, René QGCM, Nooij, Marianne A, Rodenhuis, Sjoerd, Span, Paul N, Tjan-Heijnen, Vivianne CG, de Vries, Elisabeth GE, Harris, Nathan, Twisk, Jos WR, Schellens, Jan HM, Beijnen, Jos H
Publicado em 2008

High-Dose Chemotherapy With Autologous Stem-Cell Support As Adjuvant Therapy in Breast Cancer: Overview of 15 Randomized Trials

Por Berry, Donald A., Ueno, Naoto T., Johnson, Marcella M., Lei, Xiudong, Caputo, Jean, Rodenhuis, Sjoerd, Peters, William P., Leonard, Robert C., Barlow, William E., Tallman, Martin S., Bergh, Jonas, Nitz, Ulrike A., Gianni, Alessandro M., Basser, Russell L., Zander, Axel R., Coombes, R. Charles, Roché, Henri, Tokuda, Yutaka, de Vries, Elisabeth G.E., Hortobagyi, Gabriel N., Crown, John P., Pedrazzoli, Paolo, Bregni, Marco, Demirer, Taner
Publicado no J Clin Oncol (2011)